SYShiayin F. Yang

Shiayin F. Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shiayin F. Yang has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Scott J. Stephan

    Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology—Head and Neck Surgery Vanderbilt University Medical Center Nashville Tennessee USA

    16 shared publications
  • Priyesh N. Patel

    Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA

    10 shared publications
  • Priyesh N. Patel

    Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology—Head and Neck Surgery Vanderbilt University Medical Center Nashville Tennessee USA

    7 shared publications
  • Rahul K. Sharma

    Department of Otolaryngology‐Head & Neck Surgery Vanderbilt University Medical Center Nashville Tennessee USA

    7 shared publications
  • Alexander J. Barna

    Department of Otolaryngology—Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA

    4 shared publications
  • Alexandra S. Ortiz

    Department of Otolaryngology—Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA

    4 shared publications

Latest Publications

  • Open Access

    Racial and Ethnic Disparities in Facial Paralysis: Diagnosis, Comorbidities, and Chemodenervation

    by Amy Wang, Alexander J. Barna, Eric X. Wei, Scott J. Stephan, Priyesh N. Patel, Shiayin F. Yang

    Objectives: Facial paralysis (FP) is associated with significant functional and psychosocial morbidity, yet potential racial and ethnic disparities in its diagnosis, associated comorbidities, and treatment patterns remain poorly characterized. Methods: Patients with FP diagnoses were identified using International Classification of Diseases codes within the TriNetX Database. Cohorts of Caucasian and non‐Caucasian (Black, Hispanic, and Asian) patients were matched for age and sex. Data on demographics, comorbidities, and chemodenervation rates were compared. Results: A total of 370,574 patients with a diagnosis related to FP were identified, of which 25.1% were non‐Caucasian. Caucasian patients were less likely to be diagnosed with FP (OR 0.828, p < 0.0001) at rates of 7.1 versus 8.5 cases per 1000 individuals. Non‐Caucasian FP patients were younger at time of diagnosis (mean 54.6 vs. 61.8 years), had a higher burden of Type 2 diabetes and hypertension, but lower rates of thyroid disease ( p < 0.0001). Non‐Caucasian FP patients were more likely than Caucasian counterparts to experience health hazards related to socioeconomic/psychosocial circumstances at rates of 10.2% vs. 7.1% ( p < 0.0001). Notably, Caucasian FP patients received significantly more treatments with chemodenervation compared to non‐Caucasian FP patients (OR 1.648, 95% CI, p < 0.0001). Conclusion: Non‐Caucasian patients may be more likely to be diagnosed with FP and experience more medical comorbidities compared to Caucasian patients; however, they may receive fewer chemodenervation treatments. Future studies should seek to investigate underlying differences in FP diagnosis as well as the true incidence of facial synkinesis among different racial and ethnic groups. Level of Evidence: 3.

  • Open Access

    The Impact of Social Determinants of Health on Facial Synkinesis Severity

    by Alexander J. Barna, Amy Wang, Nicole G. DeSisto, Rahul K. Sharma, Scott J. Stephan, Priyesh N. Patel, Shiayin F. Yang


  • Open Access

    The Social Network of Otolaryngology: Collaborative Publishing Relationships by Gender

    by Niketna Vivek, Evan Clark, Lily Gao, Kirsten Nguyen, Liping Du, Shenmeng Xu, Steven Baskauf, Kavita Prasad, Alexis Miller, Melissa Goldin, et al.

    Objective: This study aims to evaluate if gender differences exist in social connectedness (betweenness centrality) and professional impact (h‐indices) within Otolaryngology when controlling for variables such as academic rank, subspecialty, and geographic region. Methods: Physician faculty ( n = 2494) from 129 US ACGME accredited otolaryngology programs were identified. Characteristics included gender, academic rank, sub‐specialty, and SCOPUS IDs. The co‐authorship network was visualized and consisted of 2265 physicians (nodes) connected by 28,408 collaborative relationships (edges). The professional connectedness of physicians was calculated using betweenness centrality (BWC), which quantifies how frequently a physician node appears on the shortest path between two other nodes. Analysis employed ordinal regression fitting semiparametric multivariable cumulative probability models. Results: Among 2265 faculty physicians identified, 69% were male, 26% were female, and 5% were unknown. Female faculty had lower h‐index and BWC scores compared to their male colleagues. When controlling for subspecialty and region, male and female assistant professors did not show evidence of a difference in BWC scores (odds ratio (OR) = 0.96, p = 0.80). However, among associate and full professors, males tended to have higher BWC compared to female counterparts (OR = 1.47, p = 0.0086 for associate and OR = 2.05, p < 0.0001 for full professors). Conclusion: Analysis of our co‐authorship network showed that current male and female Otolaryngology faculty have equivalent academic impact and professional connectedness at lower academic ranks but diverge at higher ranks. These findings suggest that increased efforts to support female academic development at the mid‐career level may reduce the observed gender disparities at higher academic ranks. Level of Evidence: N/A.

  • Open Access

    Initial Treatment and Referral Patterns for Acute Facial Palsy: Insights From Emergency Department Practices

    by Christine C. Little, Rahul K. Sharma, Alexander Barna, Priyesh N. Patel, Scott J. Stephan, Shiayin F. Yang

    Objectives: To investigate variations in Bell's Palsy treatment and referrals within the Emergency Department (ED), with a focus on sociodemographic and provider‐related factors. Methods: A retrospective cohort review was performed including patients with a new diagnosis of Bell's Palsy or acute facial paralysis treated at a single, tertiary academic ED between 2017 and 2024. Management practices, including the use of steroids, antivirals, imaging, specialty consultations, and referrals, were evaluated across sociodemographic variables and provider types. Multivariable logistic regression was used to identify differences in management practices. Results: The final cohort comprised 887 patients. Of these, 82.1% received steroids, 57.7% received antivirals, and 57.3% underwent imaging. Hispanic patients were significantly less likely to receive imaging (OR 0.48, p = 0.006), whereas older patients were more likely to undergo imaging (OR 1.04, p < 0.001). Patients with Medicare and Medicaid insurance were less likely to receive bimodal therapy (steroids with antivirals) compared to private insurance holders (OR 0.30, p < 0.001 and OR 0.49, p < 0.001, respectively). Residents and fellows were more likely to obtain specialty consults (OR 2.51, p < 0.001) and imaging (OR 1.42, p = 0.043) than attending physicians. Nearly one third of patients received subspecialty consultation by neurology (26.0%), otolaryngology (6.2%), or plastic surgery (0.2%). Conclusions: Despite increasing awareness regarding the treatment of acute facial palsy, this study reveals existing disparities in initial management by age, insurance status, race, and provider type. Efforts should focus on increasing provider awareness of treatment guidelines to standardize management protocols for improved care delivery and equity. Level of Evidence: 4.


  • Applications of Artificial Intelligence in Facial Plastic and Reconstructive Surgery: A Narrative Review

    by Feyisayo O. Adegboye, April A. Peterson, Rahul K. Sharma, Scott J. Stephan, Priyesh N. Patel, Shiayin F. Yang

    Importance: Artificial intelligence (AI) has made invaluable contributions to the technologic advancements across many fields. It is transforming health care and may have a role in improving patient outcomes in facial plastic and reconstructive surgery (FPRS). Observations: In recent years, new automated approaches to simulating and analyzing outcomes using AI have emerged. Advances in rhinoplasty, facelifts, orthognathic surgery, facial reanimation, and preoperative consultation are currently being developed in FPRS. Conclusions and Relevance: Applications of AI have been applied to assist facial plastic surgeons in the preoperative stage, intraoperative planning process, and objective assessment of postoperative outcomes. The application of AI provides avenues to improve postoperative outcomes, while also optimizing patient care.


  • The Association of Mental Health Disorders with the Effectiveness of Treating Facial Synkinesis with Chemodenervation Using Botulinum Toxin A

    by Elizabeth S. Longino, Nicole G. Desisto, Alexandra S. Ortiz, Naweed I. Chowdhury, Priyesh N. Patel, Scott J. Stephan, Shiayin F. Yang

    Background: Studies suggest that mood disorders may affect perception of facial synkinesis, though none have analyzed effects on perceived benefit from chemodenervation. Objective: To measure the effect of depression, appearance anxiety, and other variables on chemodenervation benefit among patients with post-paralytic facial synkinesis. Design Type: Prospective cohort. Methods: Patients volunteered and completed: Synkinesis Assessment Questionnaire (SAQ), Facial Clinimetric Evaluation Scale (FaCE), Center for Epidemiological Studies Depression Scale (CES-D), and Fear of Negative Appearance Evaluation Scale (FNAES). Multivariate regression was used to analyze the effect of CES-D, FNAES, and demographics on pre- and post-chemodenervation SAQ and FaCE. Results: In total, 100 patients participated, 90% were female. Mean age was 56.4 (SD 12.3) years. The most common paralysis etiology was idiopathic (47%). Average synkinesis duration was 7.6 (6.2) years and treatment duration 4.9 (4.8) years. Older age and prior treatment ( p < 0.05) were associated with reduced SAQ improvement; worse CES-D approached significance ( p = 0.09). Reported history of anxiety was associated with greater SAQ improvement ( p = 0.05). Factors associated with reduced FaCE improvement included higher baseline CES-D and prior treatment ( p < 0.05). Conclusions: Older age, worse depression scores, and prior treatments may be associated with reduced patient-graded improvement following chemodenervation. History of anxiety may be associated with greater improvement.


  • Electromyography-Guided Chemodenervation for Treatment of Nonflaccid Facial Palsy: Analysis of Accuracy

    by Feyisayo O. Adegboye, Montana K. Upton, Rahul K. Sharma, Emily R. Rebula, Alexander J. Barna, Priyesh N. Patel, Scott J. Stephan, Shiayin F. Yang

    Background: Chemodenervation is a mainstay in the treatment of nonflaccid facial paralysis (NFFP). This study investigates how electromyography (EMG) guidance during chemodenervation may allow for more accurate needle placement. Study Objective: To compare the accuracy with needle EMG chemodenervation compared with standard non-EMG approaches in patients receiving treatment for NFFP with botulinum toxin (BT) as measured by physician and EMG verification. Methods: The use of needle EMG across three surgeons was recorded to determine if the use of EMG changed the location, angle, or depth of needle insertion into the targeted facial muscle. The determination of accurate needle placement was self-reported by the physician coupled with the physician assessment of muscle EMG activity. Accuracy was determined as the ratio of the number of successful EMG needle insertions (placed within muscle with adequate signal) over the total number of EMG needle insertions. Results: A total of 137 patients underwent treatment for NFFP, with an average age of 54 (interquartile range [IQR]: 44–65) and weight of 73 kg (IQR: 64–90). Of the 14 facial mimetic muscles, the posterior belly of digastric (accuracy = 19%, standard deviation [SD] 0.4), risorius (accuracy = 46%, SD 0.5), and zygomaticus (accuracy = 47%, SD 0.5) had the lowest accuracy in BT placement (Table 3). Of all the muscles included, only the buccinator ( p = 0.015), platysma ( p = 0.0093), and zygomaticus ( p = 0.024) had statistically significant variation in the accuracy of BT placement between surgeons. Conclusions: EMG guidance for the treatment of NFFP may improve the precision of needle placement and BT delivery, particularly in the mid and lower facial muscles.


  • Complications in Functional Rhinoplasty Related to Cartilage Graft Source

    by Montana K. Upton, Alexandra Ortiz, Emma Neal, Diane Lee, Priyesh N. Patel, Shiayin F. Yang, Scott J. Stephan

    Background: Functional rhinoplasty often relies on repurposed cartilage for nasal framework grafting. Objective: To compare complications in functional rhinoplasty associated with use of autologous versus fresh frozen cadaveric rib cartilage (FFCR). Methods: This retrospective cohort study included patients who underwent functional rhinoplasty from 2017 to 2022 with 6 months of documented follow-up. The primary outcome measure was need for revision rhinoplasty. Secondary outcomes were infection and persistent nasal obstruction without revision surgery. Chi-squared and Fisher’s exact tests were used for univariate analysis, and multivariable logistic regression was used to evaluate the relationship between revision surgery and covariates. Results: 259 patients (average age: 43.1 ± 16.2, 185/259 female [71.4%]) underwent functional rhinoplasty with an average of 12.3 months (range: 6–54 months) of documented follow-up. A total of 58 (22.4%) cases utilized FFCR for grafting. Overall, 15 (5.8%) patients required revision rhinoplasty (8/201 [4.0%] autologous versus 7/58 [12.1%] FFCR), while 17 (6.6%) had persistent postoperative nasal obstruction without further surgery and 12 (4.6%) had an infection requiring prescribed oral antibiotics or drainage. Compared to autologous cartilage, there was a significant association between the use of FFCR with revision rhinoplasty on logistic regression ( p = 0.024, odds ratio: 4.0 [95% confidence interval: 0.17–2.61]) but not with postoperative infection ( p = 0.101) or persistent nasal obstruction ( p = 0.187). Conclusion: These findings suggest increased rates of revision surgery associated with the use of FFCR in functional rhinoplasty. In the setting of insufficient autologous cartilage, tailored discussions should take place regarding the risks and benefits of potential supplemental graft material.


  • Intravenous Tranexamic Acid in Rhinoplasty: A Randomized Controlled Trial

    by Elizabeth S. Longino, Nicole G. Desisto, Feyi Adegboye, Emily Rebula, Naweed I. Chowdhury, Priyesh N. Patel, Scott J. Stephan, Shiayin F. Yang

    Background: Existing data on tranexamic acid (TXA) in rhinoplasty are mixed. Objective: Compare blood loss, edema, and bruising in patients undergoing septorhinoplasty with or without intravenous (IV) TXA, measured by estimated blood loss and photograph review of edema/ecchymosis. Design: Randomized controlled trial (NCT05774717). Methods: Patients undergoing open septorhinoplasty were eligible. Participants were randomized to receive 1 g IV TXA preoperatively or routine medications only. Intraoperative bleeding was measured using the Boezaart scale and sponge saturation. Patients rated periorbital edema/ecchymosis at 1 week. Photos were reviewed by a facial plastic surgeon to grade edema/ecchymosis. Results: There were 139 participants: 73 (53%) female, mean age of 42 ± 15 years, and 13% revision procedures. Sixty-nine (50%) received TXA. Boezaart scores were 2.25 and 2.41 ( p = 0.3), and sponge scores were 0.76 and 0.84 ( p = 0.4) in the TXA and control groups, respectively. Postoperative edema/ecchymosis were 1.15/1.19 out of 4 in the TXA group, and 0.97/1.05 in the control group. Surgeon-graded edema/ecchymosis were 1.78/1.76 (TXA) and 1.82/1.86 (control). There was no difference in epistaxis, pain, or appearance satisfaction. Conclusions: In this study, there was no difference in bleeding, edema, ecchymosis, or postoperative experience associated with TXA.